Pharma Focus Asia

Research Insights

Research Insights section focuses on the cutting-edge and breakthrough research that is happening all over the world. Laboratories across the globe are working hard to develop drugs and therapies for various diseases and research insights directly from them add tremendous value.

Brain High-throughput Multi-omics Data Reveal Molecular Heterogeneity in Alzheimer’s Disease

Alzheimer disease is a heterogeneous multifactorial neurodegenerative disorder pathologically characterized by amyloid plaques neurofibrillary tangles neuroinflammation and synaptic and neuronal loss

Baseline Characteristics of SARS-CoV-2 Vaccine Non-responders in a Large Population-based Sample

Individuals with certain malignancies organ transplant recipients and immunecompromised individuals could mount either an incomplete or suboptimal antibody response to primary series vaccination

SARS-CoV-2 Variant Introduction Following Spring Break Travel and Transmission Mitigation Strategies

In the spring of surging SARSCoV cases kept most universities from inperson education and adversely impacted the learning experience of college students Implementation of a salivabased RTqPCR testing strategy

A Simulation-based Comparison of Drug-drug Interaction Signal Detection Methods

Polypharmacy the use of multiple medicines has increased as the average life expectancy and the prevalence of multimorbidity has increased Adverse events

Effects of COVID-19 Vaccine Safety Framing on Parental Reactions

Despite the benefits and worldwide approval use of COVID vaccination for children parents still remain a high level of vaccine hesitancy due to concerns about vaccine safety Growing evidence showing that behavioral nudges

Unveiling Hidden Structural Patterns in the SARS-CoV-2 Genome: Computational Insights and Comparative Analysis

SARSCoV the virus responsible for covid is a member of the clade Betacoronavirus and is a positive sense single stranded RNA virus with a genome size

Drug Therapy Problems and Contributing Factors Among Patients with Epilepsy

Antiseizure medications are the mainstay of therapy in the management of epilepsy and are indicated for patients who have experienced two or more unprovoked seizures or a single unprovoked seizure accompanied

Developing Inhibitory Peptides Against SARS-CoV-2 Envelope Protein

The Coronavirus Disease pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus has affected approximately million people and counting in the world

Unravelling the Link Between SARS-CoV-2 Mutation Frequencies, Patient Comorbidities, and Structural Dynamics

The coronavirus disease was first isolated from Wuhan City Hubei Province China in December It is caused by Severe Acute Respiratory Syndrome Coronavirus a novel betacoronavirus

SARS-CoV2 Evokes Structural Brain Changes Resulting in Declined Executive Function

Coronavirus disease is caused by the severe acute respiratory syndrome coronavirus which was first identified in Wuhan China rapidly spreading around the world

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Advanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024